Pfizer Defeats Suit Challenging Diverse Student Fellowships (1)

A nationwide group representing White and Asian American applicants lacked standing to challenge a Pfizer Inc. fellowship designed to build a diverse workforce, including at the leadership level.

Do No Harm’s members include health-care professionals, students, patients, and policy-makers “who want to protect healthcare from radical, divisive, and discriminatory ideologies.” That includes “the rise in explicit racial discrimination in graduate and postgraduate medical programs,” according to the organization.

Pfizer’s “Breakthrough Fellowship” is one such program, the organization alleged in a Sept. 15 lawsuit. It sought a preliminary injunction barring the pharmaceutical maker from going forward with its 2023 application ...